# Milestone Pharmaceuticals Inc.: Form 8-K, filed Aug 12, 2026

- Company: [Milestone Pharmaceuticals Inc.](/companies/mist.md) (CIK 1408443)
- Form: 8-K
- Filed: 2026-08-12
- Accepted by EDGAR: Aug 12, 2026, 07:28 ET
- Period: 2026-08-12
- Accession: 0001104659-26-094466
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1408443/000110465926094466/tm2614433d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1408443/000110465926094466/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1408443/000110465926094466/tm2614433d1_8k.htm

Filed Aug 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-094466. Last ingested by Listed: Nov 14, 2026, 11:16 ET. No prices; not investment advice.
